Chesley Taft & Associates LLC Abbott Laboratories Transaction History

Chesley Taft & Associates LLC

  • $1.94 Billion
  • Q1 2024

A detailed history of Chesley Taft & Associates LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 237,290 shares of ABT stock, worth $24.7 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
237,290
Previous 237,501 0.09%
Holding current value
$24.7 Million
Previous $26.1 Million 3.17%
% of portfolio
1.39%
Previous 1.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$109.52 - $120.96 $23,108 - $25,522
-211 Reduced 0.09%
237,290 $27 Million
Q4 2023

Jan 11, 2024
BUY
$90.19 - $110.4 $101,734 - $124,531
1,128 Added 0.48%
237,501 $26.1 Million
Q3 2023

Oct 10, 2023
SELL
$95.53 - $114.62 $4,489 - $5,387
-47 Reduced 0.02%
236,373 $22.9 Million
Q2 2023

Jul 17, 2023
SELL
$100.78 - $112.29 $296,393 - $330,244
-2,941 Reduced 1.23%
236,420 $25.8 Million
Q1 2023

Apr 11, 2023
SELL
$96.86 - $114.01 $160,109 - $188,458
-1,653 Reduced 0.69%
239,361 $24.2 Million
Q4 2022

Jan 19, 2023
SELL
$95.06 - $111.52 $3.31 Million - $3.88 Million
-34,781 Reduced 12.61%
241,014 $0
Q3 2022

Oct 13, 2022
SELL
$96.76 - $112.03 $180,844 - $209,384
-1,869 Reduced 0.67%
275,795 $26.7 Million
Q2 2022

Jul 07, 2022
SELL
$102.07 - $123.37 $152,900 - $184,808
-1,498 Reduced 0.54%
277,664 $30.2 Million
Q1 2022

Apr 14, 2022
SELL
$114.02 - $139.04 $488,233 - $595,369
-4,282 Reduced 1.51%
279,162 $33.1 Million
Q4 2021

Jan 05, 2022
BUY
$115.53 - $141.46 $44,825 - $54,886
388 Added 0.14%
283,444 $39.9 Million
Q3 2021

Oct 05, 2021
SELL
$116.66 - $129.06 $85,045 - $94,084
-729 Reduced 0.26%
283,056 $33.4 Million
Q2 2021

Jul 07, 2021
SELL
$105.79 - $124.53 $565,764 - $665,986
-5,348 Reduced 1.85%
283,785 $32.9 Million
Q1 2021

Apr 06, 2021
SELL
$108.84 - $128.23 $821,088 - $967,367
-7,544 Reduced 2.54%
289,133 $34.7 Million
Q4 2020

Jan 11, 2021
SELL
$105.0 - $114.42 $1.07 Million - $1.17 Million
-10,220 Reduced 3.33%
296,677 $32.5 Million
Q3 2020

Oct 08, 2020
SELL
$91.64 - $111.29 $443,262 - $538,309
-4,837 Reduced 1.55%
306,897 $33.4 Million
Q2 2020

Jul 08, 2020
SELL
$76.57 - $98.0 $362,712 - $464,226
-4,737 Reduced 1.5%
311,734 $28.5 Million
Q1 2020

Apr 15, 2020
SELL
$62.82 - $91.86 $444,577 - $650,093
-7,077 Reduced 2.19%
316,471 $25 Million
Q4 2019

Jan 10, 2020
SELL
$78.51 - $87.4 $89,344 - $99,461
-1,138 Reduced 0.35%
323,548 $28.1 Million
Q3 2019

Oct 07, 2019
SELL
$81.84 - $88.74 $8,347 - $9,051
-102 Reduced 0.03%
324,686 $27.2 Million
Q2 2019

Jul 10, 2019
SELL
$72.88 - $85.0 $59,032 - $68,850
-810 Reduced 0.25%
324,788 $27.3 Million
Q1 2019

Apr 05, 2019
SELL
$66.22 - $80.06 $173,032 - $209,196
-2,613 Reduced 0.8%
325,598 $26 Million
Q4 2018

Jan 07, 2019
BUY
$65.56 - $74.27 $96,963 - $109,845
1,479 Added 0.45%
328,211 $23.7 Million
Q3 2018

Oct 12, 2018
SELL
$60.81 - $73.36 $116,451 - $140,484
-1,915 Reduced 0.58%
326,732 $24 Million
Q2 2018

Jul 12, 2018
SELL
$57.57 - $63.54 $18,537 - $20,459
-322 Reduced 0.1%
328,647 $20 Million
Q1 2018

Apr 11, 2018
SELL
$56.27 - $63.62 $112,483 - $127,176
-1,999 Reduced 0.6%
328,969 $19.7 Million
Q4 2017

Jan 10, 2018
SELL
$53.68 - $57.47 $804,448 - $861,245
-14,986 Reduced 4.33%
330,968 $18.9 Million
Q3 2017

Oct 13, 2017
BUY
$48.06 - $53.64 $16.6 Million - $18.6 Million
345,954
345,954 $18.5 Million

Others Institutions Holding ABT

# of Institutions
3,127
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email